Nerissa Kreher's most recent trade in Rezolute Inc was a trade of 25,500 Common Shares done . Disclosure was reported to the exchange on Feb. 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rezolute Inc
|
Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 25,500 | 25,500 | - | 0 | Common Shares | |
Rezolute Inc
|
Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
Rezolute Inc
|
Kreher C. Nerissa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Options (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 10,348 | 104,374 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 10,348 | 37,478 | - | 2.1 | 21,731 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 9,464 | 94,910 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 02 Aug 2023 | 9,464 | 27,130 | - | 14.7 | 139,530 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 9,464 | 36,594 | - | 2.1 | 19,874 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 02 Aug 2023 | 9,280 | 28,198 | - | 15.1 | 140,013 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 6,898 | 88,012 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 02 Aug 2023 | 6,898 | 27,130 | - | 14.1 | 97,521 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 6,898 | 34,028 | - | 2.1 | 14,486 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 02 Aug 2023 | 1,000 | 27,198 | - | 16.0 | 16,012 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.82 per share. | 02 Aug 2023 | 68 | 27,130 | - | 16.8 | 1,144 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 27,130 | - | 0 | Common Stock | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 30 Dec 2022 | 5,200 | 15,516 | - | 13.4 | 69,932 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 25 Oct 2022 | 8,040 | 28,756 | - | 2.1 | 16,884 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 8,040 | 119,682 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 25 Oct 2022 | 4,960 | 25,676 | - | 2.1 | 10,416 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 4,960 | 114,722 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.53 per share. | 25 Oct 2022 | 4,942 | 23,814 | - | 20.5 | 101,462 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 25 Oct 2022 | 4,317 | 20,716 | - | 22.0 | 95,021 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 25 Oct 2022 | 2,998 | 20,816 | - | 21.4 | 64,215 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.21 per share. | 25 Oct 2022 | 643 | 25,033 | - | 21.2 | 13,638 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.13 per share. | 25 Oct 2022 | 100 | 20,716 | - | 22.1 | 2,213 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,122 | 16,032 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 26 Sep 2022 | 3,122 | 20,716 | - | 15.2 | 47,610 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 3,122 | 23,838 | - | 2.1 | 6,556 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 3,068 | 23,784 | - | 2.1 | 6,443 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,068 | 21,557 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 26 Sep 2022 | 2,768 | 21,016 | - | 15.2 | 42,131 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 2,403 | 19,154 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.31 per share. | 26 Sep 2022 | 2,403 | 20,716 | - | 15.3 | 36,789 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 2,403 | 23,119 | - | 2.1 | 5,046 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 26 Sep 2022 | 300 | 20,716 | - | 16.3 | 4,899 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 21 Sep 2022 | 3,341 | 20,716 | - | 15.1 | 50,393 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 3,341 | 25,564 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Sep 2022 | 3,341 | 24,057 | - | 2.1 | 7,016 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 939 | 24,625 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 21 Sep 2022 | 939 | 20,716 | - | 15.1 | 14,167 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Sep 2022 | 939 | 21,655 | - | 2.1 | 1,972 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 106 | 28,905 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 15 Sep 2022 | 106 | 20,822 | - | 2.1 | 223 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 15 Sep 2022 | 106 | 20,716 | - | 15.0 | 1,591 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 08 Sep 2022 | 1,221 | 21,937 | - | 2.1 | 2,564 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 08 Sep 2022 | 1,221 | 20,716 | - | 15.1 | 18,478 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 1,221 | 29,811 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Sep 2022 | 800 | 20,716 | - | 15.1 | 12,054 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 08 Sep 2022 | 800 | 21,516 | - | 2.1 | 1,680 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 800 | 29,011 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,172 | 20,716 | - | 0 | Common Stock | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 31,032 | 31,032 | - | - | Stock Option (Right to Buy) | |
Rezolute Inc
|
Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 62,063 | 62,063 | - | - | Stock Option (Right to Buy) | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 10,344 | 15,544 | - | 0 | Common Stock | |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | 29 Dec 2021 | 5,200 | 142,722 | - | - | Stock Option (Right to Buy) | ||
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 29 Dec 2021 | 5,200 | 5,200 | - | 2.1 | 10,920 | Common Stock |
Entrada Therapeutics Inc
|
Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 72,012 | 72,012 | - | - | Stock Option (Right to Buy) | |
Rezolute Inc
|
Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |